Market Overview

Medtronic Reportedly in Merger Talks with Covidien

Medical-device maker Medtronic (NYSE: MDT) is reportedly in advanced merger talks with rival Covidien (NYSE: COV), according to sources, as reported by the Wall Street Journal. The deal, which is said to be valued at $45-$50 billion, could be announced on Monday.

Posted-In: WSJNews Rumors M&A

 

Related Articles (COV + MDT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional